Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADARB2 antisense RNA 1 (ADARB2-AS1) is a long non-coding RNA located on human chromosome 21. It does not encode a protein but has important roles in regulating gene expression at the RNA level. ADARB2-AS1 is implicated in several biological processes, including regulation of RNA metabolism, cell proliferation, and cellular differentiation. Aberrant expression of ADARB2-AS1 has been linked to diseases such as various cancers (where it may promote cell growth, invasion, or metastasis), neurodegenerative disorders like Alzheimer's and Parkinson's disease (potentially contributing to neuronal damage and cell death), and metabolic diseases such as diabetes and obesity (through possible disruption of metabolic pathways). Genetic variants in ADARB2-AS1 have been associated with increased risk for some diseases, notably Alzheimer’s disease. No direct drug-targeting or biomarker use is currently established in the literature for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADARB2 antisense RNA 1 (ADARB2-AS1).